FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4324334785> ?p ?o ?g. }

• W4324334785 endingPage "109" @default.
• W4324334785 startingPage "98" @default.
• W4324334785 abstract "Sorafenib is the first line drug for hepatocellular carcinoma (HCC) therapy. However, HCC patients usually acquire resistance to sorafenib treatment within 6 months. Recent evidences have shown that anticancer drugs with antiangiogenesis effect (e.g., sorafenib) can aggravate the hypoxia microenvironment and promote the infiltration of more tumor-associated macrophages (TAMs) into the tumor tissues. Therefore, repolarization of TAMs phenotype could be expected to not only eliminate the influence of TAMs on sorafenib lethality to HCC cells, but also provide an additional anticancer effect to achieve combination therapy. However, immune side effects remain a great challenge due to the non-specific macrophage repolarization in normal tissues. We herein employed a tumor microenvironment (TME) pH-responsive nanoplatform to concurrently transport sorafenib and modified resiquimod (R848-C16). This nanoparticle (NP) platform is made with a TME pH-responsive methoxyl-poly(ethylene glycol)-b-poly(lactic-co-glycolic acid) copolymer. After intravenous administration, the co-delivery NPs could highly accumulate in the tumor tissues and then respond to the TME pH to detach their surface PEG chains. With this PEG detachment to enhance uptake by TAMs and HCC cells, the co-delivery NPs could combinatorially inhibit HCC tumor growth via sorafenib-mediated lethality to HCC cells and R848-mediated repolarization of TAMs into tumoricidal M1-like macrophages. STATEMENT OF SIGNIFICANCE: Anticancer drugs with antiangiogenesis effect (e.g., sorafenib) can aggravate the hypoxia microenvironment and promote the infiltration of more tumor-associated macrophages (TAMs) into the tumor tissues to restrict the anticancer effect. In this work, we designed and developed a tumor microenvironment (TME) pH-responsive nanoplatform for systemic co-delivery of sorafenib and resiquimod in hepatocellular carcinoma (HCC) therapy. These co-delivery NPs show high tumor accumulation and could respond to the TME pH to enhance uptake by TAMs and HCC cells. With the sorafenib-mediated lethality to HCC cells and R848-mediated repolarization of TAMs, the co-delivery NPs show a combinational inhibition of HCC tumor growth in both xenograft and orthotopic tumor models." @default.
• W4324334785 created "2023-03-16" @default.
• W4324334785 creator A5002184992 @default.
• W4324334785 creator A5029944480 @default.
• W4324334785 creator A5034973415 @default.
• W4324334785 creator A5043257116 @default.
• W4324334785 creator A5058155027 @default.
• W4324334785 creator A5072714056 @default.
• W4324334785 creator A5087148502 @default.
• W4324334785 creator A5087273879 @default.
• W4324334785 creator A5091414721 @default.
• W4324334785 date "2023-05-01" @default.
• W4324334785 modified "2023-09-28" @default.
• W4324334785 title "Repolarization of macrophages to improve sorafenib sensitivity for combination cancer therapy" @default.
• W4324334785 cites W1557991089 @default.
• W4324334785 cites W1914333242 @default.
• W4324334785 cites W1964423256 @default.
• W4324334785 cites W1970490725 @default.
• W4324334785 cites W1986031713 @default.
• W4324334785 cites W1997944395 @default.
• W4324334785 cites W2012867962 @default.
• W4324334785 cites W2014124238 @default.
• W4324334785 cites W2019879894 @default.
• W4324334785 cites W2022540958 @default.
• W4324334785 cites W2039759758 @default.
• W4324334785 cites W2061345986 @default.
• W4324334785 cites W2081685920 @default.
• W4324334785 cites W2139708381 @default.
• W4324334785 cites W2156871508 @default.
• W4324334785 cites W2164841185 @default.
• W4324334785 cites W2205830781 @default.
• W4324334785 cites W2257103983 @default.
• W4324334785 cites W2275085833 @default.
• W4324334785 cites W2334067795 @default.
• W4324334785 cites W2413359062 @default.
• W4324334785 cites W2509930573 @default.
• W4324334785 cites W2528574508 @default.
• W4324334785 cites W2554773181 @default.
• W4324334785 cites W2575553491 @default.
• W4324334785 cites W2582686270 @default.
• W4324334785 cites W2590680367 @default.
• W4324334785 cites W2593671548 @default.
• W4324334785 cites W2598230851 @default.
• W4324334785 cites W2604359753 @default.
• W4324334785 cites W2804669050 @default.
• W4324334785 cites W2809283858 @default.
• W4324334785 cites W2883204623 @default.
• W4324334785 cites W2885162827 @default.
• W4324334785 cites W2897214576 @default.
• W4324334785 cites W2897397780 @default.
• W4324334785 cites W2924232389 @default.
• W4324334785 cites W2966360207 @default.
• W4324334785 cites W2969802526 @default.
• W4324334785 cites W2999483628 @default.
• W4324334785 cites W3034448267 @default.
• W4324334785 cites W3035408975 @default.
• W4324334785 cites W3038180315 @default.
• W4324334785 cites W3080773873 @default.
• W4324334785 cites W3089495849 @default.
• W4324334785 cites W3091083933 @default.
• W4324334785 cites W3158241061 @default.
• W4324334785 cites W3182864848 @default.
• W4324334785 cites W3217069258 @default.
• W4324334785 cites W4200274169 @default.
• W4324334785 cites W4210774372 @default.
• W4324334785 cites W4211210519 @default.
• W4324334785 cites W4213384181 @default.
• W4324334785 cites W4232620598 @default.
• W4324334785 cites W4291993576 @default.
• W4324334785 doi "https://doi.org/10.1016/j.actbio.2023.03.014" @default.
• W4324334785 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36931417" @default.
• W4324334785 hasPublicationYear "2023" @default.
• W4324334785 type Work @default.
• W4324334785 citedByCount "3" @default.
• W4324334785 countsByYear W43243347852023 @default.
• W4324334785 crossrefType "journal-article" @default.
• W4324334785 hasAuthorship W4324334785A5002184992 @default.
• W4324334785 hasAuthorship W4324334785A5029944480 @default.
• W4324334785 hasAuthorship W4324334785A5034973415 @default.
• W4324334785 hasAuthorship W4324334785A5043257116 @default.
• W4324334785 hasAuthorship W4324334785A5058155027 @default.
• W4324334785 hasAuthorship W4324334785A5072714056 @default.
• W4324334785 hasAuthorship W4324334785A5087148502 @default.
• W4324334785 hasAuthorship W4324334785A5087273879 @default.
• W4324334785 hasAuthorship W4324334785A5091414721 @default.
• W4324334785 hasConcept C178790620 @default.
• W4324334785 hasConcept C185592680 @default.
• W4324334785 hasConcept C203014093 @default.
• W4324334785 hasConcept C2776107976 @default.
• W4324334785 hasConcept C2776231280 @default.
• W4324334785 hasConcept C2778019345 @default.
• W4324334785 hasConcept C2778695046 @default.
• W4324334785 hasConcept C2779820397 @default.
• W4324334785 hasConcept C2780035454 @default.
• W4324334785 hasConcept C3020616263 @default.
• W4324334785 hasConcept C502942594 @default.
• W4324334785 hasConcept C71924100 @default.
• W4324334785 hasConcept C8891405 @default.

• next